Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
5.62
-0.01 (-0.27%)
Apr 29, 2026, 11:15 AM EDT - Market open
Kalaris Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+238.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $14 | Buy | Initiates | $14 | +149.11% | Apr 16, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +238.08% | Dec 23, 2025 |
| Citizens | Citizens | Buy Initiates $20 | Buy | Initiates | $20 | +255.87% | Nov 3, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +309.25% | Sep 3, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 8, 2025 |